These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 19338138

  • 1. Renoprotective effect of the L/N-type calcium channel antagonist cilnidipine on puromycin aminonucleoside-induced nephrosis in rats.
    Takashima K, Nishiyama C, Arisaka N, Takahashi T, Souma S, Tsuda M, Hayashi M, Kasahara H, Kodama H, Tamura T, Murakami M, Kuroda J, Sato F.
    Arzneimittelforschung; 2009; 59(2):79-85. PubMed ID: 19338138
    [Abstract] [Full Text] [Related]

  • 2. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
    Toba H, Yoshida M, Tojo C, Nakano A, Oshima Y, Kojima Y, Noda K, Wang J, Kobara M, Nakata T.
    Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
    [Abstract] [Full Text] [Related]

  • 3. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
    Nakayama K, Natori Y, Sato T, Kimura T, Sugiura A, Sato H, Saito T, Ito S, Natori Y.
    J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
    [Abstract] [Full Text] [Related]

  • 4. Key molecular events in puromycin aminonucleoside nephrosis rats.
    Guan N, Ding J, Deng J, Zhang J, Yang J.
    Pathol Int; 2004 Sep; 54(9):703-11. PubMed ID: 15363039
    [Abstract] [Full Text] [Related]

  • 5. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
    Zheng Y, Shirato I, Maeda A, Kobayashi N, Liao J, Shou I, Fukui M, Tomino Y.
    J Nephrol; 2002 Sep; 15(1):36-41. PubMed ID: 11936424
    [Abstract] [Full Text] [Related]

  • 6. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
    Koide H, Nakamura T, Kimura K, Ebihara I, Nagai R, Tomino Y.
    Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
    [Abstract] [Full Text] [Related]

  • 7. Antiproteinuric effect of cilnidipine in hypertensive Japanese treated with renin-angiotensin-system inhibitors - a multicenter, open, randomized trial using 24-hour urine collection.
    Miwa Y, Tsuchihashi T, Ohta Y, Tominaga M, Kawano Y, Sasaguri T, Ueno M, Matsuoka H.
    Clin Exp Hypertens; 2010 Sep; 32(6):400-5. PubMed ID: 20828221
    [Abstract] [Full Text] [Related]

  • 8. Effect of captopril on chronic puromycin aminonucleoside nephrosis in rats.
    Radin MJ, Wilke WL, Fettman MJ.
    Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):279-82. PubMed ID: 3538253
    [Abstract] [Full Text] [Related]

  • 9. Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis.
    Ebihara I, Nakamura T, Tomino Y, Koide H.
    Nephrol Dial Transplant; 1997 May; 12(5):1001-6. PubMed ID: 9175058
    [Abstract] [Full Text] [Related]

  • 10. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.
    Okada T, Sakaguchi T, Hatamura I, Saji F, Negi S, Otani H, Muragaki Y, Kawachi H, Shigematsu T.
    Clin Exp Nephrol; 2009 Oct; 13(5):438-446. PubMed ID: 19452240
    [Abstract] [Full Text] [Related]

  • 11. [Bone mesenchymal stem cell transplantation repairs glomerular podocytes in rats with puromycin aminonucleoside-induced nephrosis].
    Yang HD, Dong C, Guan FJ, Gao LL, Zhao T, Feng BF.
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jun; 12(6):483-7. PubMed ID: 20540862
    [Abstract] [Full Text] [Related]

  • 12. Anti-proteinuric effect of an N-type calcium channel blocker, cilnidipine.
    Tsuchihashi T, Ueno M, Tominaga M, Kajioka T, Onaka U, Eto K, Goto K.
    Clin Exp Hypertens; 2005 Nov; 27(8):583-91. PubMed ID: 16303635
    [Abstract] [Full Text] [Related]

  • 13. Effects of L/N-type calcium channel antagonist, cilnidipine on progressive renal injuries in Dahl salt-sensitive rats.
    Konda T, Enomoto A, Takahara A, Yamamoto H.
    Biol Pharm Bull; 2006 May; 29(5):933-7. PubMed ID: 16651722
    [Abstract] [Full Text] [Related]

  • 14. Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte.
    Fan YY, Kohno M, Nakano D, Ohsaki H, Kobori H, Suwarni D, Ohashi N, Hitomi H, Asanuma K, Noma T, Tomino Y, Fujita T, Nishiyama A.
    J Hypertens; 2010 May; 28(5):1034-43. PubMed ID: 20411599
    [Abstract] [Full Text] [Related]

  • 15. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
    Kim BS, Park HC, Kang SW, Choi KH, Ha SK, Han DS, Lee HY.
    Yonsei Med J; 2005 Feb 28; 46(1):141-8. PubMed ID: 15744817
    [Abstract] [Full Text] [Related]

  • 16. Ultrastructural study on nephrin expression in experimental puromycin aminonucleoside nephrosis.
    Lee YK, Kwon T, Kim DJ, Huh W, Kim YG, Oh HY, Kawachi H.
    Nephrol Dial Transplant; 2004 Dec 28; 19(12):2981-6. PubMed ID: 15385636
    [Abstract] [Full Text] [Related]

  • 17. Dynamics of absolute amount of nephrin in a single podocyte in puromycin aminonucleoside nephrosis rats calculated by quantitative glomerular proteomics approach with selected reaction monitoring mode.
    Kawakami H, Kamiie J, Yasuno K, Kobayashi R, Aihara N, Shirota K.
    Nephrol Dial Transplant; 2012 Apr 28; 27(4):1324-30. PubMed ID: 21862459
    [Abstract] [Full Text] [Related]

  • 18. Effect of benidipine hydrochloride, a long-acting T-type calcium channel blocker, on blood pressure and renal function in hypertensive patients with diabetes mellitus. Analysis after switching from cilnidipine to benidipine.
    Seino H, Miyaguchi S, Yamazaki T, Ota S, Yabe R, Suzuki S.
    Arzneimittelforschung; 2007 Apr 28; 57(8):526-31. PubMed ID: 17915639
    [Abstract] [Full Text] [Related]

  • 19. Effect of zelandopam, a dopamine D1-like receptor agonist, in puromycin aminonucleoside nephrosis rats.
    Yatsu T, Aoki M, Tanaka A.
    Eur J Pharmacol; 2005 Mar 07; 510(1-2):121-6. PubMed ID: 15740732
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats.
    Aritomi S, Harada E, Sugino K, Nishimura M, Nakamura T, Takahara A.
    Clin Exp Pharmacol Physiol; 2015 Apr 07; 42(4):344-52. PubMed ID: 25582553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.